Physician profile
Samuel Burstein
NPI 1124037155
$8,089.59
in general payments reported to CMS, 2019-2025
35 companies · $1,810 in 2025
The $1,810 reported for 2025 was more than what 92% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $451 · 2020: $796 · 2021: $1,895 · 2022: $998 · 2023: $1,205 · 2024: $936 · 2025: $1,810.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,950.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,950.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,508.41 | 2020-2025 | Evenity, Otezla, Repatha |
| Janssen Pharmaceuticals, INC | $1,055.83 | 2020-2023 | Xarelto |
| Abbvie INC. | $529.17 | 2021-2025 | Ubrelvy, Qulipta, Vraylar |
| Merck Sharp & Dohme LLC | $504.38 | 2019-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Novo Nordisk INC | $486.06 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $420.24 | 2019-2025 | Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $391.19 | 2020-2024 | Jardiance, Tradjenta |
| Pfizer INC. | $350.46 | 2020-2025 | |
| Biohaven Pharmaceuticals, INC. | $335.93 | 2021 | |
| Lilly USA, LLC | $313.03 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $310.01 | 2019-2025 | Airsupra, Breztri |
| Mayne Pharma Commercial LLC | $265.59 | 2025 | Nextstellis, Annovera |
| Exact Sciences Corporation | $227.38 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Phathom Pharmaceuticals, INC. | $156.27 | 2024 | Voquezna |
| Teva Pharmaceuticals USA, INC. | $152.99 | 2020-2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $137.99 | 2019 | |
| Boston Scientific Corporation | $115.29 | 2025 | Intracept |
| Sanofi Pasteur INC. | $110.42 | 2023 | |
| Abbott Laboratories | $104.51 | 2022-2025 | Eterna |
| Regeneron Healthcare Solutions, INC. | $104.17 | 2024 | Dupixent |
| Tris Pharma INC | $80.09 | 2023 | Quillivant, Dyanavel Xr, Quillichew Er |
| Cranial Technologies, INC | $60.14 | 2020-2025 | Doc Band |
| Hologic Sales and Service, LLC | $54.03 | 2022-2023 | Aptima, Thinprep 2000 Processor |
| Biohaven Pharmaceutical Holding Company LTD. | $45.61 | 2022 | |
| Eisai INC. | $40.10 | 2020-2021 | |
| Phadia US INC. | $36.87 | 2024-2025 | Immunocap |
| Galderma Laboratories, L.P. | $29.79 | 2021 | |
| Avanir Pharmaceuticals, INC. | $25.00 | 2022 | |
| Shield Therapeutics INC | $23.86 | 2023 | Accrufer |
| Lundbeck LLC | $22.98 | 2024 | Vyepti |
| Novartis Pharmaceuticals Corporation | $22.64 | 2021 | |
| Idorsia Pharmaceuticals US INC | $19.43 | 2023 | Quviviq |
| Bayer Healthcare Pharmaceuticals INC. | $18.29 | 2023 | |
| Alk-Abello, INC | $15.99 | 2023 | Odactra, Ragwitek, Grastek |
| Amarin Pharma, INC. | $15.45 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Burstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.